Prospective evaluation plan for randomised trials of prostate cancer screening

Journal of Medical Screening

Volumn 3, Issue 2, 1996, Pages 97-104

  Auvinen, Anssi ^a  

^a STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

Author keywords

Pooled analysis; Prostate cancer; Prostate specific antigen

Indexed keywords

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROSTATE TUMOR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICS;

AGED; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS;

EID: 0030330768     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1177/096914139600300211     Document Type: Article

References (2)

1. Lu Yao G, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994;343: 251-4.
2. Brawley OW, Thompson IM. Chemoprevention of prostate cancer. Urology 1994;43:594-9.